0000059478-19-000183.txt : 20190507
0000059478-19-000183.hdr.sgml : 20190507
20190507141806
ACCESSION NUMBER: 0000059478-19-000183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190503
FILED AS OF DATE: 20190507
DATE AS OF CHANGE: 20190507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shaw Christi
CENTRAL INDEX KEY: 0001702473
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 19802500
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LILLY ELI & CO
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1112
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
4
1
wf-form4_155725307162586.xml
FORM 4
X0306
4
2019-05-03
0
0000059478
LILLY ELI & CO
LLY
0001702473
Shaw Christi
LILLY CORPORATE CENTER
INDIANAPOLIS
IN
46285
0
1
0
0
SVP and Pres., Lilly Bio-Meds
Common Stock
2019-05-03
4
S
0
7077
117.08
D
500
D
Common Stock
2019-05-03
4
S
0
500
117.99
D
0
D
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019.
This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $117.82 to $118.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Crystal T. Williams for Christi Shaw, authorization on file
2019-05-07